Medpace Holdings, Inc. (MEDP)

Market Cap	8.61B
Revenue (ttm)	2.16B
Net Income (ttm)	416.39M
Shares Out	28.74M
EPS (ttm)	13.09
PE Ratio	22.89
Forward PE	24.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	457,039
Open	295.79
Previous Close	288.77
Day's Range	293.60 - 299.97
52-Week Range	250.05 - 459.77
Beta	1.55
Analysts	Hold
Price Target	343.22 (+14.54%)
Earnings Date	Apr 21, 2025

About MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigi...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 11, 2016
• Employees: 5,900
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDP
• Website: https://www.medpace.com

Financial Performance

In 2024, Medpace Holdings's revenue was $2.11 billion, an increase of 11.84% compared to the previous year's $1.89 billion. Earnings were $404.34 million, an increase of 43.07%.

Analyst Forecast

According to 10 analysts, the average rating for MEDP stock is "Hold." The 12-month stock price forecast is $343.22, which is an increase of 14.54% from the latest price.

Price Target

$343.22

(14.54% upside)

Analyst Consensus: Hold